How to manage radial artery spasm in a patient undergoing radial angioplasty or at the time of sheath removal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Radial Artery Spasm During Radial Angioplasty or Sheath Removal

Administer intra-arterial calcium channel blockers (verapamil 2.5-5 mg, diltiazem 2.5-5 mg, or nicardipine 250-500 μg) combined with nitroglycerin 100-200 μg immediately after sheath insertion, with repeat dosing before catheter exchanges or sheath removal. 1, 2

Pharmacological Management Algorithm

First-Line Preventive Therapy (Administer After Sheath Insertion)

  • Calcium channel blocker via intra-arterial route: 1, 2

    • Verapamil 2.5-5 mg, OR
    • Diltiazem 2.5-5 mg, OR
    • Nicardipine 250-500 μg
  • Nitroglycerin 100-200 μg intra-arterially, coadministered with the calcium channel blocker due to nitroglycerin's short pharmacological half-life 1, 2, 3

  • Repeat dosing of spasmolytics with each catheter exchange and before sheath removal 1

Evidence for Combination Therapy

  • The combination of verapamil 2.5 mg plus molsidomine 1 mg reduced spasm rates to 4.9% compared to 22.2% with placebo (P<0.0001) 4

  • A spasmolytic cocktail containing verapamil 5 mg plus nitroglycerin 200 μg reduced severe spasm (maximal pullback force >1.0 kg) to 8% versus 22% without treatment (P=0.029) 5

  • The American Heart Association guideline emphasizes that while the optimal agent combination is not definitively established, most evidence supports calcium channel blockers with nitroglycerin 1

Adjunctive Non-Pharmacological Measures

Environmental and Comfort Interventions

  • Maintain a warm environment and apply warm compresses to the access site to reduce sympathetic tone 1, 6

  • Administer mild to moderate sedation with low-dose fentanyl/midazolam combination, which reduces spasm incidence from 8.3% to 2.6% (P<0.001) and decreases access site crossover from 15.0% to 9.9% (P=0.001) 1, 2

  • Apply topical lidocaine at the puncture site to reduce pain, though intra-arterial lidocaine is not effective 1

Management of Established Severe Spasm

When Standard Measures Fail

  • Wait with continued sedation while applying warm compresses and administering additional intra-arterial vasodilators 7, 8

  • ViperSlide lubricant injection into the sheath can facilitate extraction when conventional vasodilator therapy fails to allow sheath removal 7

  • "Homemade sheathless technique": If the diagnostic catheter can advance but the sheath cannot, consider withdrawing the sheath while maintaining the catheter position, then carefully cutting away the excess sheath to create a sheathless system 8

  • Nerve block or general anesthesia should be considered only after all other measures have failed 7

Critical Safety Contraindications and Cautions

Absolute Contraindications to Spasmolytics

  • Avoid nitroglycerin in patients who have taken phosphodiesterase inhibitors (sildenafil within 24 hours, tadalafil within 48 hours) 2, 3

  • Avoid in systolic blood pressure <90 mmHg, as vasodilators may reduce central organ perfusion 3

Relative Contraindications Requiring Extreme Caution

  • Cardiogenic shock 1, 2, 3

  • Severely reduced ejection fraction 1, 2, 3

  • Severe aortic stenosis 1, 2, 3

  • Hypovolemic patients, as nitroglycerin's venodilating effects can cause cardiovascular decompensation through decreased preload 3

Common Pitfalls to Avoid

  • Do not omit anticoagulation: Administer unfractionated heparin 50 U/kg up to 5000 U to all patients (including those on therapeutic oral anticoagulation) to prevent radial artery occlusion 1, 2

  • Do not rely on nitroglycerin alone: Its short half-life necessitates coadministration with calcium channel blockers for sustained effect 1, 2, 3

  • Do not exceed nitroglycerin 100 μg per injection when using intra-arterial administration, as excessive doses may cause serious hypotensive adverse events 3

  • Do not use hydrophilic angle-tip wires initially: Prefer 1.5-mm-radius J-tip 0.035-inch wires to minimize vessel wall contact and associated trauma that triggers spasm 1

  • Do not administer spasmolytics prophylactically in hemodynamically unstable patients without first assessing intravascular volume status and concurrent medication effects 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Radial Access Cocktail: Recommended Dosages

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Local Nitroglycerin Application for Arterial Puncture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of arterial spasm during percutaneous coronary interventions through radial artery: the SPASM study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006

Research

Evaluation of a spasmolytic cocktail to prevent radial artery spasm during coronary procedures.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2003

Guideline

Physiological Mechanism of Warm Compress in Treating Radial Artery Vasospasm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.